Fortress Biotech, Inc. — Form D

Fortress Biotech, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-06-08. The offering totals $27.5M, of which $4.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Raymond J TesiDirectorLa Jolla, CA
Elizabeth J MooreExecutive OfficerSeattle, WA
Linda J RogersExecutive OfficerSeattle, WA
Raymond J TesiExecutive OfficerLa Jolla, CA
MICHAEL W ROGERSDirectorNEW YORK, NY
Bobby W SandageDirectorSt. Louis, MO
Bobby W SandageExecutive OfficerSt. Louis, MO
J. Jay LobellDirectorMiami, FL
Linda RogersExecutive OfficerColorado Springs, CO
Bertrand LiangDirectorTel Aviv, L3
Glenn L CooperDirectorWALTHAM, MA
Glenn L CooperExecutive OfficerWALTHAM, MA
George K AvgerinosExecutive OfficerNew York, NY
Dov K KleinDirectorNew York, NY
Malcolm A HoenleinDirectorNew York, NY
Jimmie A Harvey, Jr.DirectorNew York, NY
Eric K RowinskyDirectorNew York, NY
Michael A WeissDirectorNew York, NY
Michael A WeissExecutive OfficerNew York, NY
Robyn A HunterExecutive OfficerNew York, NY
Jimmie S Harvey, Jr.DirectorNew York, NY
Malcolm S HoenleinDirectorNew York, NY
Lucy S LuExecutive OfficerNew York, NY
Jimmie Jay HarveyDirectorNew York, NY
Dale W RitterExecutive OfficerNew York, NY

Other filings by this issuer (9)

FiledFormOfferingSold
2018-03-13D$30.0M$6.5M
2017-04-19D$3.3M
2011-07-05D/A$28.8M$25.8M
2011-06-06D$26.8M$2.7M
2011-05-09D$82K
2011-02-08D$69K
2011-01-19D$14.1M$14.1M
2010-05-07D$7.7M$7.0M
2009-08-04D$3.5M$1.2M

More